Castle Biosciences, Inc.
CSTL
$21.98
$0.843.97%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 20.58% | 21.78% | 15.16% | 3.08% | -6.00% |
Total Receivables | 33.72% | 35.83% | 46.86% | 53.99% | 63.15% |
Inventory | 2.43% | 13.92% | 30.91% | 69.14% | 99.55% |
Prepaid Expenses | 21.92% | 14.89% | 9.90% | -8.47% | 1.37% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 21.82% | 23.30% | 19.09% | 9.10% | 1.15% |
|
|||||
Total Current Assets | 21.82% | 23.30% | 19.09% | 9.10% | 1.15% |
Net Property, Plant & Equipment | 66.16% | 66.11% | 56.81% | 51.29% | 42.43% |
Long-term Investments | 0.00% | 0.00% | -0.08% | -0.07% | 0.00% |
Goodwill | 0.00% | 0.00% | -0.08% | -0.07% | 0.00% |
Total Other Intangibles | -10.41% | -8.30% | -8.12% | -7.96% | -7.79% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -18.43% | 1.14% | 57.55% | 38.11% | 19.75% |
Total Assets | 17.18% | 18.01% | 14.55% | 7.41% | 1.34% |
|
|||||
Total Accounts Payable | -32.79% | -1.72% | 33.71% | -6.46% | 117.04% |
Total Accrued Expenses | 9.77% | 26.05% | 14.75% | 14.81% | 20.72% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 69.21% | 59.95% | -37.64% | -33.16% | -37.25% |
Total Finance Division Other Current Liabilities | 86.86% | 39.74% | 113.17% | 98.96% | 250.56% |
Total Other Current Liabilities | 86.86% | 39.74% | 113.17% | 98.96% | 250.56% |
Total Current Liabilities | 3.62% | 21.94% | 17.02% | 6.02% | 31.94% |
|
|||||
Total Current Liabilities | 3.62% | 21.94% | 17.02% | 6.02% | 31.94% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 3.23% | 11.20% | 11.89% | 24.40% | 22.15% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 680.10% | 856.92% | -- | -53.29% | -51.87% |
Total Liabilities | 21.47% | 46.33% | 36.00% | 34.27% | 28.83% |
|
|||||
Common Stock & APIC | 7.58% | 8.09% | 8.21% | 8.36% | 8.76% |
Retained Earnings | 8.36% | 2.82% | -1.48% | -16.20% | -35.71% |
Treasury Stock & Other | 69.12% | 766.20% | -19.44% | 18.38% | 135.70% |
Total Common Equity | 16.50% | 14.33% | 11.91% | 4.50% | -1.97% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 16.50% | 14.33% | 11.91% | 4.50% | -1.97% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 16.50% | 14.33% | 11.91% | 4.50% | -1.97% |
|